As we wrap up an exciting week, we are thinking again of the thousands of people worldwide living with #ATTR amyloidosis. We intend to move rapidly to advance NTLA-2001 through the clinic in hopes of halting and even reversing the painful progression of all types of #ATTR. https://t.co/eoGSpFGg6F